Clinical trials: Male Erectile Dysfunction
Erectile Dysfunction, Vascular Disease Detected
Simvastatin for Treating Erectile Dysfunction
This is a randomized clinical trial, double-blind, placebo controlled, to verify if simvastatin can improve erectile dysfunction in men with endothelial dysfunction, without any cardiac disease.It is hypothesized that the…
- Conditions
- Erectile Dysfunction, Vascular Disease Detected, C Reactive Protein
- Trial name
- STED (NCT00947323)
- Testing
- Simvastatin
- Volunteers
- 41 people
- Sponsor
- Santa Casa de Porto Alegre
Erectile Dysfunction
Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers
This is a single dose open-label comparative pharmacokinetic study to assess the pharmacokinetic characteristics of sildenafil between HIP0908 (chewable tablet) and Viagra (tablet) in healthy male subjects.
- Trial name
- NCT01514903
- Testing
- HIP0908, viagra
- Where
- South Korea
- Volunteers
- 54 people, healthy volunteers welcome
- Sponsor
- Hanmi Pharmaceutical Company Limited
Erectile Dysfunction, Stem Cells
Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes
Diabetes is a major concern in public health because of its high frequency and its negative consequences. Erectile dysfunction (ED) is present, regardless of age, in 50 to 75% of men with diabetes.
- Conditions
- Erectile Dysfunction, Stem Cells, Diabetes Mellitus, Type 1
- Trial name
- MESERIC (NCT03361631)
- Testing
- Autologous Bone Marrow derived Mesenchymal Stem Cells
- Volunteers
- 13 people
- Sponsor
- Central Hospital, Nancy, France
Erectile Dysfunction
Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older.
This study investigates the safety and efficacy of a new dosage form of Vardenafil, an orodispersible tablet (ODT), and compares it to the safety and efficacy of a placebo (inactive) tablet in the treatment of erectile…
- Trial name
- NCT00655629
- Testing
- Vardenafil ODT (STAXYN, BAY38-9456)
- Where
- 40 sites in United States, Australia and 2 more
- Volunteers
- 339 people
- Sponsor
- Bayer
Erectile Dysfunction
To Assess the Safety of Avanafil in Healthy and Hepatically Impaired Male Subjects.
The objective of this study is to assess the single dose pharmacokinetics of avanafil in subjects with hepatic impairment and in healthy control subjects.
- Trial name
- avanafil (NCT01054430)
- Testing
- avanafil
- Volunteers
- 27 people, healthy volunteers welcome
- Sponsor
- VIVUS LLC
Erectile Dysfunction
Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile Dysfunction
Erectile dysfunction (ED) is defined as the inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance.Erectile dysfunction (ED) is one of the commonest disorders in adult males and affects…
- Trial name
- NCT07761806
- Testing
- Tadalafil 5mg
- Where
- Egypt
- Volunteers
- 75 people
- Sponsor
- Ain Shams University
Erectile Dysfunction, Erectile Dysfunction Due to Venous Disorder
Shaeer's Vein Ligation-II: Internal Pudendal Vein Perineal Ligation For Veno Occlusive Erectile Dysfunction
The goal of this interventional study is to evaluate a new surgical technique (Shaeer's Perineal Internal Pudendal Vein Ligation (SHAEER-II)) in patients with deep system veno-occlusive erectile dysfunction (VOD) .
- Trial name
- Shaeer-II (NCT06121674)
- Testing
- Shaeer-II, PPI
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Kasr El Aini Hospital
Erectile Dysfunction
Platelet-Rich Plasma Alone Versus PRP Plus Low-Intensity Shock Wave Therapy for Erectile Dysfunction
Erectile dysfunction is a common condition that may result from vascular, neurological, hormonal, psychological, or medication-related factors.
- Trial name
- NCT07783347
- Testing
- Platelet-Rich Plasma, Low-Intensity Extracorporeal Shock Wave Therapy
- Where
- Egypt
- Volunteers
- 80 people
- Sponsor
- Benha University
Erectile Dysfunction, Prostate Cancer
Intra-operative Neuromodulation of the Pelvic Plexus
The purpose of this study is to evaluate the feasibility of electrical stimulation of nerves responsible for erectile function to evoke penile erection after surgery to remove the prostate (prostatectomy).
- Trial name
- NCT03425240
- Testing
- Nerve Stimulation
- Where
- Greece
- Volunteers
- 20 people
- Sponsor
- Laikο General Hospital, Athens
Radical Prostatectomy, Erectile Dysfunction Following Radical Prostatectomy
EVERiST: Impact of Image Detected Accessory Pudendal Artery on Erection Recovery After Nerve Sparing Prostatectomy
Prostate cancer is the most common cancer amongst men in the United Kingdom, and two common curative treatments are surgery to remove the prostate (radical prostatectomy) or radiotherapy.
- Conditions
- Radical Prostatectomy, Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction Due to Arterial Insufficiency, Robotic Radical Prostatectomy
- Trial name
- EVERiST (NCT07597798)
- Testing
- Robotic Radical Prostatectomy, Penile doppler ultrasound
- Where
- United Kingdom
- Volunteers
- 40 people
- Sponsor
- University College, London
Erectile Dysfunction
A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg
This is a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel design study to evaluate effects on semen characteristics after 40 weeks of daily dosing with 20 mg tadalafil.
- Trial name
- NCT00382135
- Testing
- tadalafil
- Where
- United States
- Volunteers
- 282 people, healthy volunteers welcome
- Sponsor
- Eli Lilly and Company
Abdominal Aortic Aneurysm, Erectile Dysfunction
Screening for Aortic Aneurysms in Inland Norway
The number of AAA-surgeries performed per capita is 3-4 times higher in Innlandet county, as compared to Oslo. The last three years the annual incidence of AAA requiring treatment has been 21.5 / 100 000 inhabitants in Innlandet…
- Conditions
- Abdominal Aortic Aneurysm, Erectile Dysfunction, Quality of Life
- Trial name
- NOR-AORTA (NCT06403423)
- Where
- Norway
- Volunteers
- 240 people, healthy volunteers welcome
- Sponsor
- Sykehuset Innlandet HF
Erectile Dysfunction, Premature Ejaculation
The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation
The aim is to investigate the effectiveness of exercise in the treatment of erectile dysfunction and premature ejaculation.
- Trial name
- NCT07442396
- Testing
- control, exercise
- Where
- Turkey (Türkiye)
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Uskudar University
Sexual Dysfunction, Male Erectile Dysfunction
Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II
This trial is to provide additional important information on the impact of the treatment of the man its ED with vardenafil on partnership.
- Trial name
- NCT00377793
- Testing
- Levitra (Vardenafil, BAY38-9456)
- Where
- 47 sites in Belgium, France and 5 more
- Volunteers
- 352 people
- Sponsor
- Bayer
Erectile Dysfunction, Cardiovascular Diseases
Echocardiography in Men With Erectile Dysfunction
Cardiovascular disease is the leading cause of morbidity and mortality in the world. To curb disease development, there is, therefore, a need to identify more people at increased risk.
- Conditions
- Erectile Dysfunction, Cardiovascular Diseases, Cardiac Disease
- Trial name
- NCT05285280
- Testing
- Echocardiography
- Where
- Denmark
- Volunteers
- 386 people
- Sponsor
- Herlev and Gentofte Hospital
Erectile Dysfunction
Efficacy of Intracavernosal as add-on Therapy to Sildenafil 100 mg on Demand Compared to Sildenafil 100 mg on Demand for the Treatment of Erectile Dysfunction (ED) Not Sufficiently Responsive to Standard Therapy With Phosphodiesterase Type 5 Inhibitors
The primary objective of this study is to investigate the efficacy of intracavernosal (Xeomin®) (100U) as add-on therapy to sildenafil 100 mg on demand in men with ED and insufficient response to standard therapy with 100 mg…
- Trial name
- MENOX (NCT05196308)
- Testing
- Investigational product administration Xeomin® (MERZ PHARMACEUTICALS GMBH)
- Where
- France
- Volunteers
- 226 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Prostate Cancer, Erectile Dysfunction
Pentafecta Outcomes After Robot-assisted Laparoscopic Radical Prostatectomy
Robot-assisted laparoscopic radical prostatectomy (RALRP) is a surgical technique for the treatment of prostate cancer. The aim of this study was to report our initial experience with RALRP, by applying the concept of pentafecta.
- Conditions
- Prostate Cancer, Erectile Dysfunction, Complication of Surgical Procedure, Urinary Incontinence
- Trial name
- NCT03706508
- Testing
- Robot-assisted laparoscopic radical prostatectomy
- Where
- Brazil
- Volunteers
- 120 people
- Sponsor
- Hospital de Clinicas de Porto Alegre
Erectile Dysfunction
Platelet-Rich Plasma With or Without Tadalafil for Erectile Dysfunction
Platelet-rich plasma is being studied as a regenerative treatment option for erectile dysfunction, but it is unclear whether adding daily tadalafil gives additional benefit over platelet-rich plasma alone.
- Trial name
- NCT07602608
- Testing
- Tadalafil, Intracavernosal Platelet-Rich Plasma Injection
- Where
- Egypt
- Volunteers
- 160 people
- Sponsor
- Benha University
Sexual Dysfunction, Shock Wave
Effects of Low-intensity Shockwave Therapy Versus Kegel Exercises on Arteriogenic Erectile Dysfunction in DM Patients
To assess the effectiveness of low-intensity shockwave therapy (Li-ESWT) in the management of Arteriogenic erectile dysfunction in diabetic patients.
- Trial name
- NCT06058832
- Testing
- Low-intensity Shockwave Therapy, Kegel Exercises
- Where
- Egypt
- Volunteers
- 90 people
- Sponsor
- Cairo University
Erectile Dysfunction, Andropause
Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile Dysfunction
Observational study to evaluate the effect of Tadalafil 5mg once daily on Erectile Dysfunction and QOL in Andropause patients with Erectile Dysfunction. Patients will be observed for 8weeks.
- Trial name
- NCT02943356
- Testing
- Tadalafil
- Where
- South Korea
- Volunteers
- 40 people
- Sponsor
- The Catholic University of Korea